LDS/Medical Tests/AFF2 (AF4/FMR2 family, member 2) Gene Mutation Analysis

AFF2 (AF4/FMR2 family, member 2) Gene Mutation Analysis

AFF2 gene is located in the long (q) arm of the X chromosome at position 28. This gene encodes a putative transcriptional activator that is a member of the AF4\FMR2 gene family. This gene is associated with the folate sensitive fragile XE locus on chromosome X. Upstream of the AFF2 there are typically 4-40 CCG (Cytosine, Cytosine, Guanine) trinucleotide repeats. An expansion in the number of these repeats may destabilize and silence the gene and is the primary cause of a disorder of intellectual disability known as Fragile XE syndrome.

Fragile XE syndrome, also known as FRAXE mental retardation syndrome is an X-linked disorder with an estimated frequency of 1 in 25,000 to 100,000 newborn males. It is characterized by impaired thinking and cognitive functioning with mild intellectual disability. In most of the cases, the diagnosis is established by identifying an expansion (typically > 200) of the CCG trinucleotides repeats in the AFF2 gene. The repeat expansion causes the gene to be unstable leading to impaired production of AFF2 protein. Individuals with 50 – 200 CCG-repeat blocks are considered to have a premutation allele. Such individuals do not have fragile XE syndrome but may have an increased risk of repeat instability and expansion to a full mutation in their offspring. In some rare cases, fragile XE syndrome is associated with small deletions of nucleotide segments of the AFF2 Gene.

  • Diagnostic confirmation of fragile XE syndrome
  • Carrier screening for those with a family history
  • Prenatal carrier screening for family planning
Increase in CCG repeats is diagnostic of Fragile XE syndrome

Normal alleles: 4 – 40 CCG repeats

Premutation alleles: 50 – 200 CCG repeats

Full mutation alleles: > 200 CCG repeats

Polymerase Chain Reaction (PCR) to amplify CCG trinucleotide repeats on AFF2 gene, Next-generation sequencing, conventional sequencing.

Whole Blood collected (EDTA), confluent cultured cells, amniotic fluid, extracted genomic DNA.

Stability

  • Ambient: 3-5 days
  • Refrigeration: 7-14 days
  • Frozen: avoid freezing whole blood.
FMR1 gene mutation analysis, chromosome analysis.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login